Excess Adiposity Plays Role in Postmenopausal HR-Positive Breast Cancer

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 17, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Oct. 17, 2024 -- Excess body fat plays a role in postmenopausal hormone receptor-positive breast cancer, which could be underestimated using only body mass index (BMI), according to a study published online Oct. 17 in the Journal of Epidemiology and Community Health.

Naiara Cubelos-Fernández, from the University of León Institute of Biomedicine in Spain, and colleagues conducted a case-control study of 1,033 breast cancer cases and 1,143 postmenopausal population controls to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and the Clínica Universidad de Navarra-Body Adiposity Estimator (CUN-BAE). Odds ratios were calculated and the population attributable fraction (PAF) of excess weight related to breast cancer was estimated for both measures.

The researchers found that excess body weight attributable to the risk for breast cancer was 23.0 and 38.0 percent when using a BMI value ≥30 kg/m2 and when using a CUN-BAE value of ≥40 percent body fat, respectively. These differences in PAFs were only seen in hormone receptor-positive cases, with an estimated burden of 19.9 and 41.9 percent for BMI and CUN-BAE, respectively.

"This information could influence cancer prevention initiatives by highlighting the role of excess body fat in the development of breast cancer and by raising awareness among health care professionals and the public," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-18 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords